Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03269175
What this trial is testing

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

Who this might be right for
Multiple Sclerosis
Bayer 261
Not applicableLooking for participantsNCT05154370
What this trial is testing

China National Registry of Neuro-Inflammatory Diseases

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderClinically Isolated Syndrome+4 more
Beijing Tiantan Hospital 10,000
Large-scale testing (Phase 3)Ended earlyNCT04291456
What this trial is testing

Minocycline in MS: Confirmation of Benefit

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
University of Calgary 9
Not applicableEnded earlyNCT03926637
What this trial is testing

Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 3,073
Not applicableEnded earlyNCT01567553
What this trial is testing

The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.

Who this might be right for
Multiple Sclerosis (MS)Inflammatory Disease
Rennes University Hospital 37
Large-scale testing (Phase 3)Study completedNCT00287079
What this trial is testing

A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 35
Testing effectiveness (Phase 2)Ended earlyNCT00624468
What this trial is testing

Atacicept in Subjects With Optic Neuritis

Who this might be right for
Optic Neuritis
EMD Serono 34
Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Not applicableUnknownNCT02361697
What this trial is testing

DTI in Children With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis - Relapsing RemittingClinically Isolated Syndrome, CNS Demyelinating
University Hospital Muenster 15
Not applicableUnknownNCT03586986
What this trial is testing

Risk Factors in Early Multiple Sclerosis

Who this might be right for
Multiple SclerosisMagnetic Resonance ImagingBiomarkers+2 more
University of Colorado, Denver 300
Not applicableStudy completedNCT00787657
What this trial is testing

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Bayer 1,723
Not applicableStudy completedNCT01592474
What this trial is testing

Evaluation of Brain Atrophy in CIS Patients on Avonex

Who this might be right for
Multiple Sclerosis
University at Buffalo 180
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Lakefront Biotherapeutics NV 15
Large-scale testing (Phase 3)Study completedNCT01167426
What this trial is testing

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 148
Not applicableStudy completedNCT04038541
What this trial is testing

Prebiotic vs Probiotic in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Columbia University 37
Not applicableStudy completedNCT02695394
What this trial is testing

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 60
Early research (Phase 1)Study completedNCT00616733
What this trial is testing

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Daiichi Sankyo 25
Not applicableActive Not RecruitingNCT00445367
What this trial is testing

Biobank For MS And Other Demyelinating Diseases

Who this might be right for
Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more
Accelerated Cure Project for Multiple Sclerosis 3,226
Testing effectiveness (Phase 2)Study completedNCT00094172
What this trial is testing

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Not applicableEnrolling By InvitationNCT07032246
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study

Who this might be right for
Multiple SclerosisRadiologically Isolated SyndromeClinically Isolated Syndrome
icometrix 750
Next Page